13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 38 holding rows worth $1,070,704,000.
- Accession
- 0001085146-21-000797
- Filer
- CIK 1544773
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 38 entries on the cover page, a total value of $1,070,704,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,070,704,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 528,964 | $80,291,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,710,803 | $79,381,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 330,000 | $72,481,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 584,885 | $71,268,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 3,532,738 | $69,348,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 4,480,163 | $65,410,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 893,499 | $64,797,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 908,953 | $59,282,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,729,709 | $55,031,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 2,299,829 | $52,574,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 557,095 | $39,297,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,401,703 | $37,299,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 425,000 | $36,095,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 7,349,621 | $30,501,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 484,671 | $27,660,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 3,287,745 | $27,584,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 631,215 | $27,351,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 3,515,944 | $22,678,000 | thousands by filing date | |
| CASI PHARMACEUTICALS INC | 14757U109 | COM | 7,576,431 | $22,350,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 7,780,186 | $16,572,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 2,373,924 | $16,404,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 3,135,176 | $15,958,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,969,875 | $11,918,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 1,000,000 | $10,470,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 387,492 | $10,059,000 | thousands by filing date | |
| SIO GENE THERAPIES INC | 829399104 | COM | 3,186,335 | $8,858,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F500 | COM PAR | 4,074,074 | $8,474,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 2,512,800 | $8,091,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 610,000 | $6,850,000 | thousands by filing date | |
| DEERFIELD HEALTHCARE TECH AC | 244413209 | UNIT 07/16/2025 | 250,000 | $3,750,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 300,000 | $3,090,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,558,290 | $3,039,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 180,000 | $2,059,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 150,000 | $1,685,000 | thousands by filing date | |
| FS DEV CORP | 303020101 | COM CL A | 100,000 | $1,100,000 | thousands by filing date | |
| ACTINIUM PHARMACEUTICALS | 00507W206 | COM | 88,428 | $690,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 39,697 | $658,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 6,073 | $301,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-21-000797 | this filing | 2021-02-16 | acceptance time not in the bulk data set |